This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Mid-Cap Stocks That Have Almost Doubled in 2012 (Update2)

5. AthenaHealth (ATHN)

Company profile: AthenaHealth, with a market value of $2.6 billion, provides Internet-based business services to physician practices.

Investor takeaway: Its shares are up 47% this year and have a three-year average annual return of 39%. Analysts give them three "buy" ratings, two "buy/holds," 13 "holds," one "weak hold," and two "sells," according to a survey of analysts by S&P.

4. Skyworks Solutions (SWKS - Get Report)

Company profile: Skyworks Solutions, with a market value of $5 billion, makess semiconductor components for wireless handsets, including power amplifiers, integrated front-end modules, and direct conversion radios.

Investor takeaway: Its shares are up 51% this year and have a three-year average annual return of 55%. Analysts give them 11 "buy" ratings, five "buy/holds," and three "holds," according to a survey of analysts by S&P. It's expected to earn $1.87 per share this year and grow by 11% next year.

3. Tempur-Pedic International (TPX)

Company profile: Tempur-Pedic International, with a market value of $5 billion, makes viscoelastic foam mattresses, pillows, and other sleep system products, which, packaged together, can run several thousand dollars.

Investor takeaway: Its shares are up 52% this year and have a three-year average annual return of 161%. Analysts give them nine "buy" ratings, two "buy/holds," and four "holds," according to a survey of analysts by S&P. It's expected to earn $3.99 per share this year, and grow by 17% to $4.67 in 2013.

2. Fossil (FOSL - Get Report)

Company profile: Fossil, with a market value of $8 billion, makes wristwatches under the Fossil, Relic and Zodiac brand names, along with a complementary line of leather goods, sunglasses and jewelry. Its products are sold in department and specialty retail stores.

Investor takeaway: Its shares are up 55% this year and have a three-year average annual return of 119%. Analysts give them five "buy" ratings, five "buy/holds," and five "holds," per S&P. S&P, which has it "buy"-rated with a $125 price target, an 11% premium.

1. Regeneron (REGN - Get Report)

Company profile: Regeneron, with a market value of $10 billion, discovers, develops, and commercializes products that fight inflammation, cancer, and eye disease. Last year, it won FDA approval and launched EYLEA for the treatment of wet age-related macular degeneration.

Investor takeaway: Its shares are up 89% this year and have a three-year average annual return of 102%. Analysts give them eight "buy" ratings, one "buy/hold," and seven "holds," according to a survey of analysts by S&P. S&P has it rated "hold," due to its recent share-price jump, but said it has a "robust" pipeline of potential new products.

>>To see these stocks in action, visit the 10 Mid-Cap Stocks That Have Almost Doubled in 2012 portfolio on Stockpickr.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
PMTC $0.00 0.00%
LSI $0.00 0.00%
FOSL $59.74 0.00%
REGN $499.99 0.00%
SWKS $83.37 0.00%

Markets

Chart of I:DJI
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASDAQ 4,683.9190 -49.5780 -1.05%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs